Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Amarin Corporation PLC (AMRN)

« Back to company index

AMRN Chatter Timeline

Stock Ticker for AMRN

Most Active Tweeters for AMRN

UserTweets
@yudi_lks 9
@MatthewTNatale 6
@chiragontwtr 6
@hedgiesinvest 4
@ra_fun 4

Recent Tweets for AMRN

StockPyf @StockPyf
Take a look at this Watchlist: $AMRN $ARTL #scnDollHiVol DateTime: 2020-10-19 15:48 ET
October 19th 2020, 3:10pm
GivemeOcean @GivemeOcean
@jimcramer You made a great call on $amrn too at $21 to buy
October 19th 2020, 1:10pm
hedgiesinvest @hedgiesinvest
$AMRN If Shareholders can raise $10k in a few days, then file an Amicus we can certainly pursue a derivative suit.… https://t.co/1NriOKbqP1
October 19th 2020, 12:10pm
YuZhu4 @YuZhu4
RT @TerraPharma1: ? Fierce Biotech: The Top 10 Takeover Targets in Biopharma Coming in at Number 2 is Amarin $AMRN #vascepa https://t.c…
October 19th 2020, 10:10am
otcdynamics @otcdynamics
$AMRN Amarin to Report Third Quarter 2020 Results and Host Conference Call on November 5, 2020 https://t.co/tOoM2pKrvg
October 19th 2020, 7:10am
nubostongeorge @nubostongeorge
$AMRN - Amarin to Report Third Quarter 2020 Results and Host Conference Call on November 5, 2020 https://t.co/NFy9ztdlJ1
October 19th 2020, 7:10am
VisualStockRSRC @VisualStockRSRC
$AMRN - Amarin to Report Third Quarter 2020 Results and Host Conference Call on November 5, 2020 https://t.co/WNeM0XTUbI
October 19th 2020, 7:10am
FlashAlert_me @FlashAlert_me
$AMRN [15s. delayed]: Issued Press Release on October 19, 07:00:00: Amarin to Report Third Quarter 2020 Results and… https://t.co/VAkNZGuZXQ
October 19th 2020, 7:10am
stock_titan @stock_titan
$AMRN Amarin to Report Third Quarter 2020 Results and Host Conference Call on November 5, 2020 https://t.co/9Q4dKxpgVu
October 19th 2020, 7:10am
TerraPharma1 @TerraPharma1
? Fierce Biotech: The Top 10 Takeover Targets in Biopharma Coming in at Number 2 is Amarin $AMRN #vascepa… https://t.co/L0MVo3BgrG
October 19th 2020, 6:10am
FaZe_VascepA @FaZe_VascepA
$AMRN 0.7 KD bot jizzes on 5 guys for miracle clutch WOW #CallofDutyModernWarfare #XboxShare #FaZe5 @barnidgefan https://t.co/bnGSwnYGRk
October 18th 2020, 7:10pm
FaZe_VascepA @FaZe_VascepA
https://t.co/NmExQW3HDU #Warzone Buy Back Duos — absolute heaters #Elite ? #XboxShare $AMRN $ACB 20bombincoming
October 17th 2020, 1:10pm
ConvictionCap_ @ConvictionCap_
$amrn interesting to see amicus pop up last night, although most likely meaningless. Expecting to see en banc denie… https://t.co/dTwWhtQoL5
October 17th 2020, 10:10am
curtis_withers @curtis_withers
RT @AJDWIEN: Analysis of Amarin's Vascepa to drive increased market share, says Piper Sandler Price Target: 21$ $amrn #amarin #vascepa htt…
October 16th 2020, 8:10pm
Jb_118 @Jb_118
@tuduylinh @semodough Agree. $AMRN got notified of their AdCom (and delayed PDUFA) 40-45 days prior to their first… https://t.co/DAVRLzZQ0a
October 16th 2020, 5:10pm
YuZhu4 @YuZhu4
RT @ra_fun: "Piper Sandler analyst Yasmeen Rahimi keeps an Overweight rating and $21 price target on Amarin..." $AMRN https://t.co/AWw22sr…
October 16th 2020, 4:10pm
hedgiesinvest @hedgiesinvest
$AMRN What is management doing to promote shareholder value? How about talking to the FDA about adding Evaporate to… https://t.co/onPRPhGuM8
October 16th 2020, 2:10pm
mchaudhry82 @mchaudhry82
$AMRN Amarin call volume above normal and directionally bullish https://t.co/Tqj5ayg2Sw
October 16th 2020, 1:10pm
bocadmk @bocadmk
$amrn 50 day has moved down to 5.41. matter of hours...
October 16th 2020, 12:10pm
OG_Cdquality @OG_Cdquality
RT @kylewdennis: Love it on $AMRN! https://t.co/IBdM0vKNao
October 16th 2020, 12:10pm
gcassidy718 @gcassidy718
$AMRN "Everything is impossible until someone does it" 2.02 % change recently https://t.co/ptfWB4ucJa
October 16th 2020, 12:10pm
Orangeman1992 @Orangeman1992
@MedResCol How many shares at $1.34. I have no skin in the game. But I followed you on $AMRN
October 16th 2020, 11:10am
AJDWIEN @AJDWIEN
Analysis of Amarin's Vascepa to drive increased market share, says Piper Sandler Price Target: 21$ $amrn #amarin… https://t.co/rmzffNDyWz
October 16th 2020, 10:10am
jannik_reiners @jannik_reiners
$AMRN Federal circuit judges consulting regarding en banc review. https://t.co/SJiiLNOXOi
October 16th 2020, 10:10am
yudi_lks @yudi_lks
RT @Pharmdca: Great drug Vascepa unfortunately company couldn’t convince and lost on the patent war $AMRN
October 15th 2020, 7:10pm
yudi_lks @yudi_lks
RT @JorelLaraKalel: Amarin gains after Vascepa found to significantly reduce ischemic events in PCI patients $AMRN https://t.co/wDEPt35QNw…
October 15th 2020, 7:10pm
yudi_lks @yudi_lks
RT @AmpBioResearch: $AMRN - VASCEPA® Found to Significantly Reduce Ischemic Events in Patients with Prior Percutaneous Coronary Interventio…
October 15th 2020, 7:10pm
yudi_lks @yudi_lks
RT @MarcJacksonLA: $AMRN Vascepa Found To Significantly Reduce Ischemic Events In Patients With Prior Percutaneous Coronary Intervention (P…
October 15th 2020, 7:10pm
yudi_lks @yudi_lks
RT @HealthcareBeat: Amarin gains after Vascepa found to significantly reduce ischemic events in PCI patients $AMRN https://t.co/eGqQ8SXTWI
October 15th 2020, 7:10pm
HealthcareBeat @HealthcareBeat
Amarin gains after Vascepa found to significantly reduce ischemic events in PCI patients $AMRN https://t.co/eGqQ8SXTWI
October 15th 2020, 7:10pm
MarcJacksonLA @MarcJacksonLA
$AMRN Vascepa Found To Significantly Reduce Ischemic Events In Patients With Prior Percutaneous Coronary Interventi… https://t.co/pnNdbfo3N0
October 15th 2020, 7:10pm
AmpBioResearch @AmpBioResearch
$AMRN - VASCEPA® Found to Significantly Reduce Ischemic Events in Patients with Prior Percutaneous Coronary Interve… https://t.co/rRI90pAhIL
October 15th 2020, 5:10pm
bocadmk @bocadmk
$amrn oh boy...
October 15th 2020, 5:10pm
justinburkhard1 @justinburkhard1
RT @BioStocks: $AMRN VASCEPA Found to Significantly Reduce Ischemic Events in Patients with Prior Percutaneous Coronary Intervention (PCI)…
October 15th 2020, 4:10pm
darylmox @darylmox
RT @Pharmdca: Great drug Vascepa unfortunately company couldn’t convince and lost on the patent war $AMRN https://t.co/2LcvlSDhrA
October 15th 2020, 4:10pm
MarketCurrents @MarketCurrents
$AMRN - Amarin gains after Vascepa found to significantly reduce ischemic events in PCI patients https://t.co/TnakQLIyhj
October 15th 2020, 4:10pm
ArmengolRivera @ArmengolRivera
Watching $AMRN and see if it curls on good news
October 15th 2020, 4:10pm
TerraPharma1 @TerraPharma1
$HLS.TO $AMRN https://t.co/tj3QaxlcxM
October 15th 2020, 4:10pm
quant_data @quant_data
Amarin Highlights Presentation Of REDUCE-IT Study Of VASCEPA Related Tickers: $AMRN
October 15th 2020, 4:10pm
Pharmdca @Pharmdca
Great drug Vascepa unfortunately company couldn’t convince and lost on the patent war $AMRN https://t.co/2LcvlSDhrA
October 15th 2020, 4:10pm
leopoldtrader73 @leopoldtrader73
$AMRN bot for long term hold here 5.25
October 15th 2020, 4:10pm
PhDInvestor @PhDInvestor
Here we go again. $AMRN https://t.co/KiRtDtmqA9
October 15th 2020, 4:10pm
BioStocks @BioStocks
$AMRN VASCEPA Found to Significantly Reduce Ischemic Events in Patients with Prior Percutaneous Coronary Interventi… https://t.co/TmMW5XpCKu
October 15th 2020, 4:10pm
SwingTradeIdeas @SwingTradeIdeas
$AMRN is up 5.54% after hours on 268,589 volume. Now trading at $5.33. #AMRN #afterhoursscan
October 15th 2020, 4:10pm
otcdynamics @otcdynamics
$AMRN VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Percutaneous… https://t.co/XNHqEldoWh
October 15th 2020, 4:10pm
Junior21503501 @Junior21503501
Watching $AMRN Consistent and robust benefit news.. Keeping an eye on it
October 15th 2020, 4:10pm
biobuddha @biobuddha
2020: The rise and fall of $AMRN vs the fall and rise of $TRIL! What a year!
October 15th 2020, 4:10pm
SwingTradeIdeas @SwingTradeIdeas
$AMRN is up 8.51% after hours on 195,823 volume. Now trading at $5.48. #AMRN #afterhoursscan
October 15th 2020, 4:10pm
sbwcws @sbwcws
Amarin shares jump 9.3% after Vascepa data in patients with prior PCI $AMRN
October 15th 2020, 4:10pm
nubostongeorge @nubostongeorge
$AMRN - VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior https://t.co/CHhPm8kaXW
October 15th 2020, 4:10pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.